C. Micha Nübling

2.2k total citations
49 papers, 1.4k citations indexed

About

C. Micha Nübling is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, C. Micha Nübling has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 25 papers in Hepatology and 24 papers in Epidemiology. Recurrent topics in C. Micha Nübling's work include Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (20 papers) and Viral gastroenteritis research and epidemiology (9 papers). C. Micha Nübling is often cited by papers focused on Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (20 papers) and Viral gastroenteritis research and epidemiology (9 papers). C. Micha Nübling collaborates with scholars based in Germany, United States and United Kingdom. C. Micha Nübling's co-authors include Sally A. Baylis, Johannes Blümel, Michael Chudy, Johannes Löwer, Kay-Martin Hanschmann, Heinrich Scheiblauer, Julia Kreß, Rainer Seitz, M. Chudy and Erhard Seifried and has published in prestigious journals such as Applied and Environmental Microbiology, Hepatology and Journal of Clinical Microbiology.

In The Last Decade

C. Micha Nübling

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Micha Nübling Germany 23 691 576 542 111 97 49 1.4k
R. Stefan Roß Germany 20 824 1.2× 908 1.6× 380 0.7× 101 0.9× 78 0.8× 50 1.4k
Shirley Owusu‐Ofori Ghana 23 491 0.7× 630 1.1× 282 0.5× 74 0.7× 45 0.5× 61 1.6k
Cyrille Bisseyé Gabon 21 267 0.4× 618 1.1× 289 0.5× 93 0.8× 135 1.4× 97 1.5k
J. Gillon United Kingdom 22 398 0.6× 535 0.9× 417 0.8× 22 0.2× 61 0.6× 52 1.7k
Joseph C. Forbi United States 21 866 1.3× 857 1.5× 358 0.7× 107 1.0× 121 1.2× 55 1.3k
C.L. van der Poel Netherlands 26 2.0k 2.9× 1.9k 3.4× 332 0.6× 139 1.3× 147 1.5× 75 2.8k
Chong‐Gee Teo United Kingdom 19 1.8k 2.6× 1.4k 2.4× 587 1.1× 53 0.5× 64 0.7× 43 2.1k
Anne‐Marie Roque‐Afonso France 27 1.9k 2.8× 1.5k 2.6× 804 1.5× 52 0.5× 78 0.8× 104 2.5k
Jaime Guardia Spain 27 2.3k 3.4× 2.2k 3.8× 301 0.6× 46 0.4× 166 1.7× 58 2.9k
Bruce A. Lenes United States 14 113 0.2× 444 0.8× 309 0.6× 240 2.2× 50 0.5× 19 1.7k

Countries citing papers authored by C. Micha Nübling

Since Specialization
Citations

This map shows the geographic impact of C. Micha Nübling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Micha Nübling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Micha Nübling more than expected).

Fields of papers citing papers by C. Micha Nübling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Micha Nübling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Micha Nübling. The network helps show where C. Micha Nübling may publish in the future.

Co-authorship network of co-authors of C. Micha Nübling

This figure shows the co-authorship network connecting the top 25 collaborators of C. Micha Nübling. A scholar is included among the top collaborators of C. Micha Nübling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Micha Nübling. C. Micha Nübling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nübling, C. Micha, et al.. (2023). Regulation of blood-screening in vitro diagnostics in sub-Saharan African countries remains a challenge. Frontiers in Medicine. 10. 1252721–1252721.
3.
Scheiblauer, Heinrich, Andreas Nitsche, Andreas Puyskens, et al.. (2021). Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Eurosurveillance. 26(44). 73 indexed citations
4.
Chudy, M., C. Micha Nübling, Johannes Blümel, A Daas, & Antonio Costanzo. (2017). Establishment of the Ph. Eur. Hepatitis A virus RNA for NAT testing BRP batch 1.. PubMed. 2017. 29–43. 2 indexed citations
5.
Peiffer, Kai‐Henrik, Dieter Glebe, Andreas Reuter, et al.. (2016). Comparative characterization of hepatitis B virus surface antigen derived from different hepatitis B virus genotypes. Virology. 502. 1–12. 22 indexed citations
6.
Baylis, Sally A., Michael Chudy, & C. Micha Nübling. (2015). Standardization of NAT for Blood-Borne Pathogens. Transfusion Medicine and Hemotherapy. 42(4). 211–218. 10 indexed citations
7.
Laperche, Syria, C. Micha Nübling, Susan L. Stramer, et al.. (2015). Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples. Transfusion. 55(10). 2489–2498. 19 indexed citations
8.
Nübling, C. Micha, Sally A. Baylis, Kay-Martin Hanschmann, et al.. (2015). World Health Organization International Standard To Harmonize Assays for Detection of Mycoplasma DNA. Applied and Environmental Microbiology. 81(17). 5694–5702. 27 indexed citations
9.
Baylis, Sally A., Johannes Blümel, Keiji Matsubayashi, et al.. (2013). World Health Organization International Standard to Harmonize Assays for Detection of Hepatitis E Virus RNA. Emerging infectious diseases. 19(5). 729–735. 120 indexed citations
10.
Chudy, M., K.‐M. Hanschmann, Sigrid Nick, et al.. (2012). First WHO International Reference Panel containing hepatitis B virus genotypes A–G for assays of the viral DNA. Journal of Clinical Virology. 55(4). 303–309. 22 indexed citations
11.
Chudy, Michael, Marijke Weber‐Schehl, Lutz Pichl, et al.. (2011). Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets. Transfusion. 52(2). 431–439. 34 indexed citations
12.
Miller, W. Greg, Gary L. Myers, Mary Lou Gantzer, et al.. (2011). Translation: Roadmap for Harmonization of Clinical Laboratory Measurement Procedures. Laboratory Medicine Online. 2(1). 1–1.
13.
Caspari, G., Detlev H. Krüger, Johannes Blümel, et al.. (2010). Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transplant Infectious Disease. 12(5). 375–386. 38 indexed citations
14.
Chudy, Michael, Kay-Martin Hanschmann, Julia Kreß, Wolfram H. Gerlich, & C. Micha Nübling. (2009). Collaborative Study to Establish a World Health Organization International Genotype Panel for Hepatitis B Virus Nucleic Acid Amplification Technique (NAT) - Based Assays. 6 indexed citations
15.
Blümel, Johannes, et al.. (2008). West Nile virus and blood product safety in Germany. Journal of Medical Virology. 80(3). 557–563. 19 indexed citations
16.
Seitz, Rainer, M. Heiden, C. Micha Nübling, G Unger, & Johannes Löwer. (2008). The harmonization of the regulation of blood products: a European perspective. Vox Sanguinis. 94(4). 267–276. 23 indexed citations
17.
Schmidt, Michael, C. Micha Nübling, Heinrich Scheiblauer, et al.. (2006). Anti‐HBc screening of blood donors: a comparison of nine anti‐HBc tests. Vox Sanguinis. 91(3). 237–243. 57 indexed citations
18.
Nübling, C. Micha, Michael Chudy, Peter Volkers, & Johannes Löwer. (2006). Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection. Transfusion. 46(11). 1886–1891. 19 indexed citations
19.
Nübling, C. Micha, et al.. (2002). Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase. Transfusion. 42(8). 1037–1045. 77 indexed citations
20.
Nübling, C. Micha, Albrecht Gröner, & Johannes Löwer. (1998). GB Virus C/Hepatitis G Virus and Intravenous Immunoglobulins. Vox Sanguinis. 75(3). 189–192. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026